Low iron levels can damage your kidneys through several distinct pathways, and the relationship runs in both directions. Iron deficiency starves kidney cells of the energy they need to function, worsens the oxygen supply problems that drive kidney disease forward, and independently raises the risk of kidney decline and death even when full-blown anemia has not yet developed. At the same time, failing kidneys make iron deficiency worse by disrupting the hormones that regulate iron absorption. This two-way relationship has prompted researchers to treat iron deficiency not as a mere side effect of kidney disease but as an active contributor to it.
What Iron Deficiency Does to Kidney Cells
Your kidneys are among the most energy-hungry organs in your body. The cells lining the kidney’s filtering tubes rely heavily on tiny power plants called mitochondria, which burn oxygen to generate the energy those cells need to reabsorb nutrients and keep your blood chemistry in balance. Iron sits at the heart of that energy-production process. Several of the key protein complexes inside mitochondria depend on iron-containing clusters to pass electrons along and produce energy.
When researchers deprived human kidney tubular cells of iron in laboratory experiments, the cells’ baseline oxygen consumption dropped to roughly a third of normal levels. The activity of three of the four major energy-generating complexes inside mitochondria fell by about 23 to 27 percent compared to cells with adequate iron. When iron was restored, both oxygen consumption and complex activity returned to normal, confirming that the damage was directly tied to iron status rather than some other variable.1Nephrology Dialysis Transplantation. Mitochondrial oxidative phosphorylation in human proximal tubular epithelial cells is impaired by iron deficiency—Additional Report The proteins that form these complexes were also reduced in iron-deficient cells, with one dropping to about 38 percent of its normal level.2Nephrology Dialysis Transplantation. Mitochondrial oxidative phosphorylation in human proximal tubular epithelial cells is impaired by iron deficiency
This matters because kidney tubular cells cannot easily switch to alternative energy sources. When their mitochondria underperform, the cells become vulnerable to injury and, over time, to the kind of scarring that turns acute damage into permanent kidney loss.
The Oxygen Problem
Iron deficiency often leads to anemia, and anemia means fewer red blood cells carrying oxygen through your bloodstream. Kidneys are particularly sensitive to drops in oxygen because their inner tissue already operates in a relatively low-oxygen environment under normal conditions. When anemia reduces oxygen delivery further, kidney tissue enters a state of chronic oxygen starvation.
That oxygen deficit triggers a cascade of harmful events: inflammation rises, cells that promote scarring migrate into kidney tissue, and the proteins that form scar tissue accumulate between functioning kidney cells. Over time, this fibrosis replaces healthy tissue with non-functional scar tissue, progressively reducing the kidney’s ability to filter blood.3PubMed Central. Anemia and Hypoxia Impact on Chronic Kidney Disease Onset and Progression: Review and Updates The process is self-reinforcing: as kidney function declines, the kidney produces less erythropoietin (the hormone that tells your bone marrow to make red blood cells), which worsens anemia, which deepens the oxygen deficit.
Iron Deficiency Without Anemia Still Raises Risk
One of the more striking findings in recent years is that iron deficiency appears to harm kidneys even before hemoglobin drops low enough to qualify as anemia. A study of chronic kidney disease patients who did not have anemia found that those with low iron saturation had a roughly 66 percent higher risk of their kidney disease getting worse compared to patients with adequate iron stores. The same group faced more than double the risk of dying from any cause.4PubMed Central. Association of iron deficiency with kidney outcome and all-cause mortality in chronic kidney disease patients without anemia
Separate research looking at a broader population of people with chronic kidney disease who were not on dialysis found that iron deficiency independently raised the risk of death by about 28 percent and the risk of heart failure by about 34 percent, after accounting for other health differences between patients.5PubMed Central. Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease Another analysis found that people with the lowest iron saturation levels had the highest risks for both death and major cardiovascular events, with the sweet spot for lowest risk appearing at an iron saturation of about 40 percent.6PubMed Central. Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia
These findings suggest that checking only hemoglobin and declaring a patient “not anemic” misses a meaningful piece of the picture. Iron status itself, independent of whether someone is anemic, appears to matter for kidney outcomes.
The Vicious Cycle of Heart Failure, Kidney Disease, and Iron Deficiency
Heart failure and kidney disease tend to travel together. When one organ weakens, it strains the other: a failing heart delivers less blood to the kidneys, and struggling kidneys retain fluid that overloads the heart. Iron deficiency and anemia sit squarely in the middle of this cycle, worsening both conditions simultaneously.7PubMed Central. Anemia Management in the Cardiorenal Patient: A Nephrological Perspective
This overlap has been formalized as the “cardiorenal anemia iron deficiency syndrome,” reflecting the recognition that all four problems feed into each other.8PubMed Central. A Role of Sodium-Glucose Co-Transporter 2 in Cardiorenal Anemia Iron Deficiency Syndrome Some researchers have argued that iron deficiency deserves its own place in the syndrome name, separate from anemia, because correcting iron stores can improve heart function even when hemoglobin levels barely budge.9European Journal of Heart Failure. Beyond the Cardiorenal Anaemia Syndrome: Recognizing the Role of Iron Deficiency The practical takeaway is that if you have either heart or kidney problems, your doctor should be checking your iron status, not just your blood count.
How Kidney Disease Makes Iron Deficiency Worse
The kidney itself plays a central role in regulating iron throughout the body, which is why the relationship between iron and kidney health is not a one-way street. A hormone called hepcidin acts as the body’s master switch for iron: when hepcidin levels are high, iron absorption from food slows down and iron already in the body gets locked inside storage cells where it cannot be used to make red blood cells.
In chronic kidney disease, two things conspire to push hepcidin levels too high. First, the chronic inflammation that accompanies kidney disease stimulates hepcidin production. Second, the kidneys normally help clear hepcidin from the blood; when they are impaired, hepcidin accumulates. The result is a state of “functional iron deficiency,” where the body may have adequate iron stores but cannot mobilize them for use. This iron trapping makes people resistant to erythropoietin, meaning even injectable versions of the red-blood-cell-stimulating hormone work poorly when iron is locked away.10PubMed Central. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease
This distinction between “absolute” iron deficiency (not enough iron in the body) and “functional” iron deficiency (enough iron in storage but unable to access it) is clinically important because the two conditions are treated differently and measured differently.
Why Standard Iron Tests Can Be Misleading in Kidney Patients
Diagnosing iron deficiency in someone with kidney disease is trickier than checking a simple ferritin level. Ferritin, the most commonly ordered iron test, doubles as both an iron-storage marker and an inflammation marker. Because kidney disease involves chronic inflammation, ferritin can be misleadingly normal or even elevated in someone who is functionally iron deficient.
Clinicians working with kidney patients rely on a combination of markers. A transferrin saturation below 20 percent combined with low ferritin points to a true shortage of iron in the body. The same low saturation combined with normal or high ferritin signals functional iron deficiency, where the iron exists but is trapped. Research has also shown that the maximum response to erythropoietin-stimulating drugs is reached at saturation levels above 30 percent, and that transferrin saturation measurements fluctuate considerably from day to day in the same person, sometimes by as much as 38 percent.11PubMed Central. Markers of Iron Status in Chronic Kidney Disease That variability means a single blood draw can be unreliable, and repeated testing or a broader panel of markers gives a more accurate picture.
Iron Deficiency Before Birth Can Permanently Change Kidney Structure
The connection between iron and kidneys starts before birth. Kidneys form most of their filtering units (nephrons) during late pregnancy and shortly after birth, and this process depends on adequate iron. Once that developmental window closes, you cannot grow new nephrons. Whatever count you end up with is what you have for life.
In rat studies, offspring born to iron-deficient mothers had markedly smaller kidneys with fewer and smaller filtering units. Glomerular density dropped by 26 percent, and the surface area of each glomerulus shrank by 29 percent. Supplementing iron partially rescued kidney growth, confirming that iron was the limiting factor.12Pediatric Research. Iron Deficiency and Renal Development in the Newborn Rat Further research found that this effect was sex-dependent: male offspring of iron-restricted mothers had about 21 percent fewer nephrons, while female offspring were largely spared. The mechanism appeared to involve disruption of vitamin A metabolism in the developing kidney, which is essential for nephron formation.13PubMed. Perinatal iron deficiency causes sex-dependent alterations in renal retinoic acid signaling and nephrogenesis
These are animal studies, and the exact numbers would differ in humans. But the principle is well established in developmental biology: a lower nephron count at birth is a risk factor for high blood pressure and kidney disease later in life. Maternal iron deficiency, which remains common globally, could be contributing to kidney disease risk in ways that do not become apparent for decades.
Iron, Bacteria, and Urinary Tract Infections
Iron’s role in kidney health takes an unexpected turn when it comes to infections. The bacteria that cause most urinary tract infections, particularly a strain of E. coli, need iron to survive and multiply inside your body. Your immune system has evolved a strategy to fight this: when infection is detected, hepcidin rises to sequester iron away from invading bacteria, essentially starving them out.
Mouse experiments showed that animals on a low-iron diet harbored significantly fewer bacteria in their bladders during urinary tract infections and had less inflammation than mice with normal iron status.14PubMed Central. Dietary restriction of iron availability attenuates UPEC pathogenesis in a mouse model of urinary tract infection Separately, mice lacking hepcidin entirely showed a dramatic increase in bacterial burden in their kidneys during experimental infections, while pretreating normal mice with extra hepcidin dampened bacterial invasion. The bacteria themselves appeared to suppress hepcidin production in kidney cells as an escape strategy.15PubMed Central. Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coli
This creates an interesting tension in clinical care. Iron deficiency harms kidney function through the energy and oxygen mechanisms described earlier, but iron restriction also helps fight certain kidney infections. This is part of why blanket iron supplementation without checking for active infection is something clinicians need to approach thoughtfully.
Treating Iron Deficiency in People With Kidney Disease
Iron replacement is a mainstay of managing anemia in kidney disease. In patients with chronic kidney disease, intravenous iron raises hemoglobin more effectively and consistently than oral iron tablets. However, a Cochrane review pooling data from over a thousand participants across eight studies found that iron therapy made little measurable difference to the actual rate at which the kidneys filter blood.16PubMed Central. Parenteral versus oral iron therapy for adults and children with chronic kidney disease In other words, while iron therapy clearly helps with anemia, the evidence that it directly improves kidney filtration is thin so far.
There is also a paradox with intravenous iron: giving a large dose of free iron all at once can temporarily generate oxidative stress in the kidneys. Within 15 to 30 minutes of an IV iron infusion, researchers observed spikes in markers of cellular damage in the blood and urine of kidney disease patients, along with a temporary increase in protein leakage from the kidneys.17PubMed. Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease Animal studies have confirmed that IV iron formulations can increase oxidative stress in the kidneys, liver, and heart.18PubMed. Evaluation of toxicity and oxidative stress induced by intravenous iron isomaltoside 1000 in a nonclinical model
This does not mean IV iron is too dangerous to use. For most kidney patients, the benefits of correcting severe iron deficiency and improving anemia outweigh these transient oxidative effects. But it does explain why nephrologists carefully dose and time IV iron infusions rather than flooding the system all at once, and why newer iron formulations have been designed to release iron more slowly.
Diabetes Compounds the Problem
People with diabetes develop anemia earlier and more frequently when kidney disease sets in compared to people whose kidney disease has other causes. The reasons are layered: diabetic kidney disease involves damage to the cells that produce erythropoietin, chronic low-grade inflammation that traps iron, and nerve damage that can impair the kidney’s ability to sense and respond to drops in oxygen levels.19PubMed Central. Anemia, diabetes, and chronic kidney disease Correcting anemia and iron deficiency in diabetic kidney disease may slow the progression of kidney damage, though figuring out the right hemoglobin target and iron-dosing strategy in this population remains an active area of clinical research.
The Gut Connection
An emerging area of research links the changes in gut bacteria seen in kidney disease to worsening anemia and iron status. As kidney function declines, waste products that would normally be filtered out of the blood accumulate and alter the composition of intestinal bacteria. The disrupted gut microbiome produces more toxic byproducts that cross into the bloodstream, promote inflammation throughout the body, and generate fewer of the beneficial short-chain fatty acids that help maintain the intestinal lining.20PubMed Central. Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease That inflammation, in turn, drives hepcidin production higher and further blocks iron absorption and mobilization. This gut-kidney-iron axis is still being mapped, but it helps explain why oral iron supplements are often poorly absorbed in advanced kidney disease, and it opens the door to possible future interventions targeting gut health as a way to improve iron status.
Iron Deficiency After Kidney Transplantation
Receiving a new kidney does not automatically fix iron deficiency. Iron depletion is extremely common in transplant recipients and can contribute to anemia both in the early months after surgery and in the long term. In this population, iron deficiency has been associated with a substantially increased risk of death independent of anemia and kidney function, with estimates ranging from 77 to 106 percent higher mortality risk.21Clinical Kidney Journal. Anemia and iron deficiency in post-kidney transplantation: an unsolved challenge
The relationship between iron status and the health of the transplanted kidney itself is less clear. One retrospective study found that higher ferritin was associated with better graft function and survival, while another found no clear link between iron markers and graft failure, though there was a trend toward better outcomes in patients who received iron therapy at the time of transplant.22Nephrology Dialysis Transplantation. Iron deficiency after kidney transplantation The scarcity of data here means transplant teams are often making iron-replacement decisions based on general principles rather than strong evidence specific to transplant recipients.
Newer Therapies Targeting the Oxygen-Iron Axis
A newer class of drugs takes a different approach to the anemia of kidney disease by manipulating the body’s own oxygen-sensing machinery. These drugs inhibit an enzyme that normally breaks down a protein called hypoxia-inducible factor, or HIF. When HIF is allowed to accumulate, it boosts the kidney’s and liver’s production of erythropoietin and simultaneously improves the body’s ability to absorb and use iron. Early clinical experience has shown that these HIF-based therapies can manage anemia effectively in kidney disease patients while improving iron metabolism.23PubMed Central. Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience Several of these agents have been approved in various countries, offering an oral alternative to injectable erythropoietin and potentially reducing the need for large IV iron doses. Whether they also slow kidney disease progression by addressing the underlying oxygen deficit remains an open question that ongoing trials are working to answer.